Other languages Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
16.81 ^CNY	-1.70%		+3.32%	-33.16%

04-26	Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-26	Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-26
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	23-10-27
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	23-10-26
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023	23-04-28
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022	23-04-18
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders	23-04-03
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022	23-03-27
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility	23-01-20
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	22-08-04
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	22-08-03
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28
Porton Pharma Solutions Ltd. Announces Final Dividend for 2021, Payable on 28 April 2022	22-04-21
Porton Pharma Solutions Ltd. Announces Board Appointments	22-04-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

Other languages

Filters